# A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions

Study · id `cardio:ct-nct02796157` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02796157](<https://clinicaltrials.gov/study/NCT02796157>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02796157

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 950 participants.

## Technical summary

Registry record NCT02796157. Randomized; no masking; primary purpose treatment. Start 2016-06 (registry gives no type); primary completion 2019-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 950 participants (planned count; ClinicalTrials.gov record NCT02796157, source copy `cardio:ctgov-nct02796157-2018-05-18`, retrieved 2026-10-26)
- Start date: 2016-06 (registry gives no type) (ClinicalTrials.gov record NCT02796157, source copy `cardio:ctgov-nct02796157-2018-05-18`, retrieved 2026-10-26)
- Primary completion: 2019-05 (anticipated) (ClinicalTrials.gov record NCT02796157, source copy `cardio:ctgov-nct02796157-2018-05-18`, retrieved 2026-10-26)
- Completion: 2019-05 (anticipated) (ClinicalTrials.gov record NCT02796157, source copy `cardio:ctgov-nct02796157-2018-05-18`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT02796157, source copy `cardio:ctgov-nct02796157-2018-05-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02796157-2018-05-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: A Randomized Comparison of Clinical Outcomes Between Everolimus-eluting Bioresorbable Vascular Scaffold Versus Everolimus-eluting Metallic Stent in Long Coronary Lesions
- Condition: Coronary Artery Disease
- Intervention (Device): PCI with Absorb everolimus-eluting bioresorbable vascular scaffold
- Intervention (Device): PCI with Xience everolimus-eluting metallic stent
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Bioresorbable Vascular Scaffolds Versus Drug-Eluting Stents for Diffuse Long Coronary Narrowings (`cardio:pubmed-32279841`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5e9e0c8c1b69f26505609ce484dc821dc5e1119d412b71c903e1929bf049090a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
